Antalis, TM and Linn, ML and Donnan, K and Mateo, L and Gardner, J and Dickinson, JL and Buttigieg, K and Suhrbier, A, “The serine proteinase inhibitor (Serpin) plasminogen activation inhibitor type 2 protects against viral cytopathic effects by constitutive interferon alpha/beta priming”, Journal of Experimental Medicine, 187 (11) pp. 1799-1811. ISSN 0022-1007 (1998) [Refereed Article] |
Data Type | Value |
Type of Research | Applied Research |
Research Division | Biomedical and Clinical Sciences |
Research Group | Medical biochemistry and metabolomics |
Research Field | Medical biochemistry - nucleic acids |
Research Objective Division | Health |
Research Objective Group | Other health |
Research Objective Field | Other health not elsewhere classified |
Visit Item on eCite | http://ecite.utas.edu.au/13931 |
Digital Object Identifier | doi:10.1084/jem.187.11.1799 |
Scopus Source URL | View the full record on Scopus |
Scopus Citing URL | View the list of citing articles on Scopus |
Web of Science® Source URL | View the full record on Web of Science® |
Web of Science® Citing URL | View the list of citing articles on Web of Science® |
Web of Science® Related URL | View the list of related articles on Web of Science® |
Number of Times Cited | 77 |